Janus Henderson Group PLC lessened its holdings in Icon Plc (NASDAQ:ICLR) by 8.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 974,043 shares of the medical research company’s stock after selling 94,116 shares during the period. Janus Henderson Group PLC owned approximately 1.80% of Icon worth $110,948,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in ICLR. Geode Capital Management LLC increased its position in Icon by 14.7% in the first quarter. Geode Capital Management LLC now owns 28,777 shares of the medical research company’s stock worth $2,294,000 after purchasing an additional 3,680 shares during the last quarter. Schwab Charles Investment Management Inc. increased its position in Icon by 22.2% in the first quarter. Schwab Charles Investment Management Inc. now owns 12,021 shares of the medical research company’s stock worth $959,000 after purchasing an additional 2,181 shares during the last quarter. US Bancorp DE increased its position in Icon by 17.1% in the second quarter. US Bancorp DE now owns 2,259 shares of the medical research company’s stock worth $221,000 after purchasing an additional 330 shares during the last quarter. IFP Advisors Inc increased its position in Icon by 3.0% in the second quarter. IFP Advisors Inc now owns 2,299 shares of the medical research company’s stock worth $225,000 after purchasing an additional 67 shares during the last quarter. Finally, Canada Pension Plan Investment Board increased its position in Icon by 669.7% in the second quarter. Canada Pension Plan Investment Board now owns 101,140 shares of the medical research company’s stock worth $9,890,000 after purchasing an additional 88,000 shares during the last quarter. Institutional investors own 89.95% of the company’s stock.

Icon Plc (NASDAQ ICLR) opened at $113.87 on Thursday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.90 and a current ratio of 1.90. Icon Plc has a 1 year low of $73.76 and a 1 year high of $124.48. The firm has a market cap of $6,104.01, a price-to-earnings ratio of 21.64, a price-to-earnings-growth ratio of 1.74 and a beta of 0.56.

Icon (NASDAQ:ICLR) last posted its quarterly earnings data on Thursday, October 26th. The medical research company reported $1.35 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.32 by $0.03. Icon had a net margin of 16.37% and a return on equity of 28.42%. The business had revenue of $440.30 million for the quarter, compared to analysts’ expectations of $438.09 million. During the same quarter in the previous year, the business posted $1.19 earnings per share. The business’s revenue was up 4.8% compared to the same quarter last year. equities research analysts expect that Icon Plc will post 5.37 EPS for the current fiscal year.

Several equities research analysts recently weighed in on the stock. Zacks Investment Research cut shares of Icon from a “buy” rating to a “hold” rating in a research report on Friday, September 22nd. Jefferies Group restated a “buy” rating and issued a $122.00 price target on shares of Icon in a research report on Tuesday, September 12th. ValuEngine cut shares of Icon from a “buy” rating to a “hold” rating in a research report on Monday, October 2nd. Barclays boosted their price target on shares of Icon from $108.00 to $120.00 and gave the stock an “equal weight” rating in a research report on Friday, October 27th. Finally, Bank of America assumed coverage on shares of Icon in a research report on Monday, September 11th. They issued a “buy” rating and a $128.00 price target on the stock. Four equities research analysts have rated the stock with a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the company’s stock. Icon presently has a consensus rating of “Buy” and an average target price of $121.00.

COPYRIGHT VIOLATION NOTICE: This piece was posted by Daily Political and is owned by of Daily Political. If you are reading this piece on another website, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this piece can be accessed at https://www.dailypolitical.com/2017/12/14/janus-henderson-group-plc-trims-position-in-icon-plc-iclr.html.

Icon Company Profile

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies.

Institutional Ownership by Quarter for Icon (NASDAQ:ICLR)

Receive News & Ratings for Icon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon and related companies with MarketBeat.com's FREE daily email newsletter.